Perspectives on Public Private Partnership: The R&D Based Vaccine Industry
Public and private stakeholders, including the industrialized countries vaccine industry, have since its launch in 2000 been a member of the Global Alliance for Vaccines and Immunization (The GAVI Alliance), a public private partnership that strives to save children’s lives and protect people’s health by increasing access to immunization in the poorest countries of the world. This paper examines the R&D-based industry’s strategic intent and operational model, and contributions to innovation, supply and delivery of vaccines. Building on the World Health Organization’s (WHO) general concept of global access to medicines, the purpose is to provide insights into the commitments as well as challenges faced by the innovation-driven industry, and this in the following main areas: (i) The Quest for Global Health – Vaccines for the World; (ii) Availability – Innovation, Manufacturing and Supply; (iii) Affordability – Universal Access, Equity and Pricing; (iv) Adoption – Financing and Public Awareness; and (v) Alliances – Building a Strong Public Private Partnership.
|Date of creation:||Nov 2011|
|Date of revision:|
|Contact details of provider:|| Postal: P.O. Box 1203, 6201 BE Maastricht|
Phone: +31 43 387 08 08
Fax: +31 43 387 08 00
Web page: http://research.msm.nl
More information through EDIRC
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Daems, Rutger & Maes, Edith & Ramani, Shyama V., 2011. "Global Framework for Differential Pricing of Pharmaceuticals," MERIT Working Papers 054, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
- David E. Bloom & David Canning & Mark Weston, 2005. "The Value of Vaccination," World Economics, World Economics, Economic & Financial Publishing, 1 Ivory Square, Plantation Wharf, London, United Kingdom, SW11 3UE, vol. 6(3), pages 15-39, July.
- DiMasi, Joseph A. & Hansen, Ronald W. & Grabowski, Henry G., 2003. "The price of innovation: new estimates of drug development costs," Journal of Health Economics, Elsevier, vol. 22(2), pages 151-185, March.
When requesting a correction, please mention this item's handle: RePEc:msm:wpaper:2011/36. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Maud de By)
If references are entirely missing, you can add them using this form.